Power, sample size and adaptation considerations in the design of group sequential clinical trials (Q3429959): Difference between revisions
From MaRDI portal
Created a new Item |
Normalize DOI. |
||
(3 intermediate revisions by 3 users not shown) | |||
Property / DOI | |||
Property / DOI: 10.1093/biomet/91.3.507 / rank | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1093/biomet/91.3.507 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2315952772 / rank | |||
Normal rank | |||
Property / DOI | |||
Property / DOI: 10.1093/BIOMET/91.3.507 / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Latest revision as of 06:38, 21 December 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Power, sample size and adaptation considerations in the design of group sequential clinical trials |
scientific article |
Statements
Power, sample size and adaptation considerations in the design of group sequential clinical trials (English)
0 references
20 March 2007
0 references
futility boundary
0 references
group sequential test
0 references
information bound
0 references